Web Stats Provided By Google Analytics

Friday, January 31, 2014

Why Enanta Pharmaceuticals Inc. Shares Soared

Enanta shares soar after it and development partner AbbVie report phase 3 results of their direct-acting antiviral combo drug for hepatitis-C.

http://ift.tt/1kmEX3T

No comments:

Post a Comment

Popular Healthcare Law Roundup Posts